Market Research Logo

Cuba Pharmaceuticals and Healthcare Report Q2 2016

Cuba Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The special development zone will allow Cuba to have greater openness in parts of its statewithout the danger of risking its entire system under the 'threat' of the free-market. The Chinese style (morefree market-oriented and flexible) governmental measures in the special development zone will providesignificant investment opportunities for pharmaceutical companies.

Headline Expenditure Projections

Pharmaceuticals: CUP1.51bn (USD1.51bn) in 2015 to CUP1.61bn (USD1.61bn) in 2016; +6.5% inlocal currency terms and US dollar terms. Forecasts have been maintained from Q116.

Healthcare: CUP7.62bn (USD7.62bn) in 2014 to CUP8.01bn (USD8.01bn) in 2016; +5.1% in localcurrency terms and US dollar terms. Forecasts have been maintained from Q415.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Cuba 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Cuba 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Cuba 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Cuba 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Cuba 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Cuba 2014-2020)
Industry Risk Reward Index
Americas Risk/Reward Index
Cuba Risk/Reward Index
Rewards
Risk
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Cuba 2010-2015)
Table: Healthcare Personnel (Cuba 2010-2015)
Table: Healthcare Activity (Cuba 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Biotechnology, Pharmaceutical & Healthcare's Members of CAMARACUBA, 2010
Table: Licensed Local Pharmaceutical Producers, April 2011
Table: Foreign Producers with GMP Certificates, April 2011
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Demographic Forecast
Table: Population Headline Indicators (Cuba 1990-2025)
Table: Key Population Ratios (Cuba 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Cuba 1990-2025)
Table: Population By Age Group (Cuba 1990-2025)
Table: Population By Age Group % (Cuba 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report